ICICI Prudential Nifty Pharma Index Fund Direct-Growth
Equity: Sectoral-Pharma - Growth (Open ended) Factsheet
SEBI Riskometer: Very HighCategory: Equity: Sectoral-PharmaBenchmark: NIFTY Pharma Total Return IndexCheck Portfolio Overlap →
NAV: ₹20.66+0.74%
07 Sept 2026
Tracking Difference
Annualised return gap between ICICI Prudential Nifty Pharma Index Fund Direct-Growth and its benchmark index over 1Y, 3Y, 5Y and 10Y periods, compared to the average of all funds tracking the same benchmark.
| Name | 1 Y | 3 Y | 5 Y | 10 Y |
|---|---|---|---|---|
| Fund | -0.63% | -0.87% | - | - |
| Avg. of funds with same benchmark | -0.63% | -0.87% | - | - |
Rolling Returns Analysis
Rolling annualized returns of ICICI Prudential Nifty Pharma Index Fund Direct-Growth across 1Y, 3Y and 5Y windows — average, best, worst returns and percentage of positive return periods.
| Metric | 1 Yr Rolling Returns | 3 Yr Rolling Returns | 5 Yr Rolling Returns | 7 Yr Rolling Returns |
|---|---|---|---|---|
| Analysis period | 22 Dec, 2023 - 07 Sep, 2026 | 01 Jan, 2026 - 07 Sep, 2026 | - | - |
| Average returns | 24.09% | 22.91% | - | - |
| Standard deviation | 20.78% | 1.76% | - | - |
| Best returns | 63.79% 1 year ending on 01 Apr, 2024 | 25.63% 3 years ending on 08 Jun, 2026 | - | - |
| Worst returns | -7.46% 1 year ending on 30 Sep, 2025 | 18.93% 3 years ending on 29 Jan, 2026 | - | - |
| Period with positive return | 88.02% | 100.00% | - | - |
| Period with return > 5% | 78.74% | 100.00% | - | - |
| Period with return > 10% | 69.31% | 100.00% | - | - |
| Period with return > 15% | 53.89% | 100.00% | - | - |
| Beat % Category | 28.59% | 0.59% | - | - |
| Beat % Benchmark | 30.09% | 0.00% | - | - |
Trailing Returns
Point-to-point returns of ICICI Prudential Nifty Pharma Index Fund Direct-Growth vs category average for YTD, 1M, 6M, 1Y, 3Y, 5Y and 10Y periods — with category rank and total funds count.
0%
10%
20%
30%
40%
17.7%
19.0%
18.1%
YTD
0.5%
0.4%
0.5%
1 M
16.2%
19.3%
16.5%
6 M
21.7%
18.3%
22.7%
1 Y
20.4%
22.8%
47.3%
3 Y
15.7%
14.0%
5 Y
15.3%
9.4%
10 Y
Fund
Equity: Sectoral-Pharma
NIFTY Pharma Total Return Index
| Name | YTD | 1 M | 6 M | 1 Y | 3 Y | 5 Y | 10 Y | Since Inception |
|---|---|---|---|---|---|---|---|---|
| Fund | 17.65% | 0.49% | 16.22% | 21.68% | 20.36% | - | - | 21.45% |
| Equity: Sectoral-Pharma | 19.02% | 0.44% | 19.32% | 18.26% | 22.79% | 15.66% | 15.35% | - |
| NIFTY Pharma Total Return Index | 18.07% | 0.52% | 16.54% | 22.74% | 47.28% | 13.97% | 9.42% | - |
| Rank in category | 14 | 11 | 17 | 7 | 8 | - | - | - |
| Funds in category | 22 | 23 | 22 | 21 | 11 | 8 | 4 | - |
Period Returns
Calendar-year, quarterly and monthly return history of ICICI Prudential Nifty Pharma Index Fund Direct-Growth. Toggle between bar chart and table view to analyse periodic performance trends.
Historical Performance
Track NAV movement and cumulative returns of ICICI Prudential Nifty Pharma Index Fund Direct-Growth across 1M, 6M, 1Y, 3Y, 5Y and since-inception periods. Compare SIP and lumpsum growth over time.
Compare performance with respect toAdd benchmark
Add benchmark
Frequently Asked Questions
What are the 1-year returns of ICICI Prudential Nifty Pharma Index Fund Direct-Growth?
ICICI Prudential Nifty Pharma Index Fund Direct-Growth has delivered a 1-year return of 21.68% as of 6 Sep 2026. During the same period, its benchmark NIFTY Pharma Total Return Index returned 22.74%. The fund has underperformed its benchmark over this period.
What are the 3-year returns of ICICI Prudential Nifty Pharma Index Fund Direct-Growth?
ICICI Prudential Nifty Pharma Index Fund Direct-Growth has delivered a 3-year CAGR of 20.36% as of 6 Sep 2026. Its benchmark NIFTY Pharma Total Return Index returned 47.28% CAGR over the same period. CAGR (Compounded Annual Growth Rate) is the right way to evaluate multi-year mutual fund performance as it smooths out year-to-year volatility.
What are the 5-year returns of ICICI Prudential Nifty Pharma Index Fund Direct-Growth?
The 5-year CAGR for ICICI Prudential Nifty Pharma Index Fund Direct-Growth is shown in the Trailing Returns section above.
What are the returns of ICICI Prudential Nifty Pharma Index Fund Direct-Growth since inception?
Since its launch on 19 Dec 2022, ICICI Prudential Nifty Pharma Index Fund Direct-Growth has delivered a CAGR of 21.45%. Since-inception returns reflect the fund's full history and give the most complete picture of long-term performance.
How has ICICI Prudential Nifty Pharma Index Fund Direct-Growth performed vs its category over the long term?
Over the long term, ICICI Prudential Nifty Pharma Index Fund Direct-Growth has ranked 8 out of 11 funds in the Equity: Sectoral-Pharma category on a 3-year basis, and - on a 5-year basis. Category rank is one of several factors to consider alongside risk metrics and rolling return consistency when evaluating a fund.
What is the Sharpe ratio of ICICI Prudential Nifty Pharma Index Fund Direct-Growth?
The Sharpe ratio of ICICI Prudential Nifty Pharma Index Fund Direct-Growth is 0.96 (as of 6 Sep 2026). The Sharpe ratio measures how much return the fund generates per unit of risk (volatility) taken. A Sharpe ratio above 1.0 is generally considered good — the higher the ratio, the better the risk-adjusted return.
What is the alpha of ICICI Prudential Nifty Pharma Index Fund Direct-Growth?
The 3Y alpha of ICICI Prudential Nifty Pharma Index Fund Direct-Growth is -0.41% (as of 6 Sep 2026). Alpha measures the excess return generated by the fund over and above its benchmark NIFTY Pharma Total Return Index, after adjusting for risk. A positive alpha means the fund manager has added value beyond what the market delivered. A negative alpha means the fund has underperformed its benchmark on a risk-adjusted basis.
What is the beta of ICICI Prudential Nifty Pharma Index Fund Direct-Growth?
The beta of ICICI Prudential Nifty Pharma Index Fund Direct-Growth is 0.94 (as of 6 Sep 2026). Beta measures how sensitive the fund is to market movements relative to its benchmark NIFTY Pharma Total Return Index. A beta of 1 means the fund moves in line with the market. A beta above 1 means it is more volatile than the market; below 1 means it is less volatile. ICICI Prudential Nifty Pharma Index Fund Direct-Growth's beta of 0.94 indicates it is more defensive than its benchmark.
What are the rolling returns of ICICI Prudential Nifty Pharma Index Fund Direct-Growth?
The average 1-year and 3-year rolling returns of ICICI Prudential Nifty Pharma Index Fund Direct-Growth is 24.09% and 22.91% respectively. Rolling returns show the fund's annualized return across every possible 1-year and 3-year investment window, making them a far more reliable measure of consistency than point-to-point returns, which depend heavily on the start and end date chosen.